139 results
Page 2 of 7
8-K
bpqurk47
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
EX-99.2
nxaxwmzb877yowqs1d
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
EX-99.1
d0z0ft80itrms6ok
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
f0uxgi2
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
S-3ASR
uiiyvdiujb a8uu4gn
9 Nov 21
Automatic shelf registration
5:05pm
DEFA14A
cktwh wwyf77svth
29 Sep 21
Additional proxy soliciting materials
12:27pm
8-K
EX-99.2
pb3 g81idd8
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-10.5
qsnhx5gphbenz2tw2ema
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-99.1
9qxazq8d29ct
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-10.1
64p tlobw
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-99.4
k8ku w4u6
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am
8-K
EX-99.1
l1oit65cjsd1xn
5 Aug 21
Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates
7:02am
8-K
EX-99.1
kvkjbd2u 2fq
14 Jun 21
Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors
7:27am
8-K
EX-99.1
gc8r6q6
8 Jun 21
Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
7:00am
8-K
jq45klygqd
8 Jun 21
Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
7:00am